Market Tracker

05/03 4:30am ET

NovaBay Pharmaceuticals Inc (NYSE MKT LLC:NBY)

2.71
Delayed Data
As of May 02
 -0.453 / -14.32%
Today’s Change
1.63
Today|||52-Week Range
26.25
+34.16%
Year-to-Date
No recent news for NovaBay Pharmaceuticals Inc.

Today’s Trading

Previous close3.16
Today’s open3.14
Day’s range2.67 - 3.38
Volume68,550
Average volume (3 months)35,922
Market cap$16.1M
Dividend yield--
Data as of 05/02/2016

Growth & Valuation

Earnings growth (last year)+12.00%
Earnings growth (this year)+67.74%
Earnings growth (next 5 years)--
Revenue growth (last year)+315.65%
P/E ratioNM
Price/Sales1.28
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CBIOCatalyst Biosciences...-0.07-4.96%
IMNPImmune Pharmaceutica...-0.00-0.50%
OPXAOpexa Therapeutics I...+0.12+5.00%
ACSTAcasti Pharma Inc0.000.00%
Data as of 05/02/2016

Financials

Last reporting dateMay 3, 2016
EPS forecast (this quarter)-$0.68
Annual revenue (last year)$4.4M
Annual profit (last year)-$19.0M
Net profit margin-433.07%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Mark M. Sieczkarek
Chief Financial Officer, Secretary &
Treasurer
Tom Paulson
Corporate headquarters
Emeryville, California

Forecasts